170 related articles for article (PubMed ID: 27293079)
21. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
22. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner.
Li Q; Ding C; Meng T; Lu W; Liu W; Hao H; Cao L
J Pharmacol Sci; 2017 Dec; 135(4):148-155. PubMed ID: 29233468
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.
Shin HJ; Baek KH; Jeon AH; Kim SJ; Jang KL; Sung YC; Kim CM; Lee CW
Oncogene; 2003 Jun; 22(25):3853-8. PubMed ID: 12813458
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity.
Wu JY; Xiang S; Zhang M; Fang B; Huang H; Kwon OK; Zhao Y; Yang Z; Bai W; Bepler G; Zhang XM
J Biol Chem; 2018 Feb; 293(6):1976-1993. PubMed ID: 29259132
[TBL] [Abstract][Full Text] [Related]
25. Sodium butyrate inhibits histone deacetylation in cultured cells.
Candido EP; Reeves R; Davie JR
Cell; 1978 May; 14(1):105-13. PubMed ID: 667927
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells.
Ho CM; Donovan-Banfield IZ; Tan L; Zhang T; Gray NS; Strang BL
PLoS One; 2016; 11(3):e0150339. PubMed ID: 26930276
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
28. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
29. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
[TBL] [Abstract][Full Text] [Related]
30. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
31. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation.
Wang H; Moreau F; Hirota CL; MacNaughton WK
FASEB J; 2010 Jun; 24(6):1971-80. PubMed ID: 20065107
[TBL] [Abstract][Full Text] [Related]
32. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
Kopp R; Fichter M; Assert R; Pfeiffer AF; Classen S
Int J Mol Med; 2009 May; 23(5):639-49. PubMed ID: 19360323
[TBL] [Abstract][Full Text] [Related]
33. Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase.
Zhang H; Du M; Yang Q; Zhu MJ
J Nutr Biochem; 2016 Jan; 27():299-306. PubMed ID: 26601598
[TBL] [Abstract][Full Text] [Related]
34. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
Mariadason JM; Corner GA; Augenlicht LH
Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
[TBL] [Abstract][Full Text] [Related]
35. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
[TBL] [Abstract][Full Text] [Related]
36. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
38. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
39. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways.
Aoyama M; Kotani J; Usami M
Nutrition; 2010 Jun; 26(6):653-61. PubMed ID: 20004081
[TBL] [Abstract][Full Text] [Related]
40. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway.
Zuo L; Lu M; Zhou Q; Wei W; Wang Y
Food Chem Toxicol; 2013 Dec; 62():892-900. PubMed ID: 24416777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
